Breathing assistance apparatus

Information

  • Patent Grant
  • 11395894
  • Patent Number
    11,395,894
  • Date Filed
    Monday, April 8, 2019
    5 years ago
  • Date Issued
    Tuesday, July 26, 2022
    2 years ago
Abstract
In one embodiment, a nasal cannula is shaped to fit within a user's nares, where the nasal cannula includes at least one prong allowing high flow delivery of humidified gases and creates positive airway pressure in the patient's airway. The prongs have angled ends such that, in use, gases flowing through the prongs are directed to the user's nasal passages. The nasal cannula body is partially swivelling and preferably has a ball joint connector. In another embodiment the nasal cannula may have at least one flared end prong that preferably seals within a patient's nare.
Description
INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS

Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference and made a part of the present disclosure.


BACKGROUND
Field

The present invention relates to apparatus for treating sleep apnea. More specifically, the present invention provides a nasal positive airway pressure device.


Description of Related Art

Obstructive Sleep Apnea (OSA) is a sleep disorder that affects up to at least 5% of the population in which muscles that normally hold the airway open relax and ultimately collapse, sealing the airway. The sleep pattern of an OSA sufferer is characterised by repeated sequences of snoring, breathing difficulty, lack of breathing, waking with a start and then returning to sleep. Often the sufferer is unaware of this pattern occurring. Sufferers of OSA usually experience daytime drowsiness and irritability due to a lack of good continuous sleep.


In an effort to treat OSA sufferers, a technique known as Continuous Positive Airway Pressure (CPAP) was devised. A CPAP device consists of a gases supply (or blower) with a conduit connected to supply pressurised gases to a patient, usually through a nasal mask. The pressurised air supplied to the patient effectively assists the muscles to keep the patient's airway open, eliminating the typical OSA sleep pattern.


The procedure for administering CPAP treatment has been well documented in both the technical and patent literature. Briefly stated, CPAP treatment acts as a pneumatic splint of the airway by the provision of a positive pressure, usually in the range 4 to 20 cm H.sub.2O. The air is supplied to the airway by a motor driven blower whose outlet passes via an air delivery hose to a nose (or nose and/or mouth) mask sealingly engaged to a patient's face by means of a harness or other headgear. An exhaust port is provided in the delivery tube proximate to the mask. More sophisticated forms of positive airway pressure devices, such as bi-level devices and auto-titrating devices, are described in U.S. Pat. No. 5,148,802 of Respironics, Inc. and U.S. Pat. No. 5,245,995 of Rescare Limited, respectively.


U.S. Pat. No. 5,477,852 of Airways Ltd, Inc. discloses a nasal positive airway pressure device that has a pair of nasal members each having a cannula tip to be inserted into the nares of the patient. Each cannula is tapered from a substantially circular cross-section outside the patient's nostril to a substantially oval cross-section at the tip inserted into the nostril. An inflatable cuff surrounds each cannula with the interior space of the cuff communicating with the lumen of the cannula through at least one aperture in the sidewall of the cannula. The nasal members are connected to one or more flexible hoses that, in turn, are connected to a source of positive air pressure. In use, positive air pressure is supplied to each cannula tip through the air hoses and nasal members. The positive air pressure inflates the cuffs to hold the nasal members in place and to effect treatment. The nasal device of U.S. Pat. No. 5,477,852 is attached to headgear that is located about a patient's head; this headgear could be considered by many patients as cumbersome and uncomfortable.


Conventional nasal masks used for administrating CPAP treatment are also considered uncomfortable and cumbersome, and prior art nasal masks and the like are noisy (due to air leaks). These disadvantages in many cases are a formidable obstacle to patient acceptance of such treatment. Therefore, a substantial number of patients either cannot tolerate treatment or choose to forego treatment. It is believed a substantial number of such patients could benefit from a nasal positive airway pressure apparatus that is more convenient to use and comfortable to wear, thereby resulting in increased treatment compliance.


As oxygen is supplied as a dry gas it is well known in the art to either heat and/or humidify gases before delivering them for breathing by a patient. In particular when delivering oxygen, or oxygen or air mixture, it has proven beneficial to humidify the gases first. In WO01/41854 of Vapotherm, Inc. a system is disclosed that allows the delivery of humidified oxygen through a nasal cannula. This system uses a narrow bore conduit and nasal cannula with a high resistance to gas flows, thereby requiring the oxygen be of a high pressure. Air, as well as oxygen can also be passed down the conduit and nasal cannula and it too must be of a high pressure. This system allows the delivery of high flows of oxygen enriched air to the patient, but is limited in the flows achievable due to the narrow bore of the cannula resulting in high resistance gas flow and excessive velocity and noise upon exiting the cannula. Furthermore, the narrowness of the nasal cannula in this system allows easy expiration of gases between the prongs and nares and therefore does not create any positive airway pressure.


Innomed Technologies, Inc. manufactures a nasal cannula device called the NASALAIRE™. In this device air or oxygen travels down a wide bore conduit to nasal cannula. The NASALAIRE™ creates a physical seal between the nares and itself, and relies on the absence of leaks around itself and the nares to deliver pressure supplied by a continuous positive airway pressure (CPAP) blower to the airway of the wearer.


SUMMARY

It is an object of the present invention to provide a breathing assistance apparatus which goes someway to overcoming the above mentioned disadvantages or which will at least provide the public a useful choice.


Accordingly in a first aspect the present invention consists in a breathing assistance apparatus comprising:


nasal cannula, shaped to fit within a user's nares, and adapted to deliver said humidified gases to said user,


a pressurised source of gases,


transportation means adapted to, in use, be in fluid communication with said source of gases and said nasal cannula and adapted to in use convey said gases to said user,


wherein said nasal cannula including at least one prong allowing high flow delivery of said humidified gases and creating a positive airway pressure in said patient's airway, said at least one prong having an angled end, such that in use, gases flowing through said prong are directed to said user's nasal passages.


In a second aspect the present invention consists in a breathing assistance apparatus comprising:


nasal cannula, shaped to fit within a user's nares,


a pressurised source of gases,


transportation means adapted to, in use, be in fluid communication with said source of gases and said nasal cannula and adapted to in use convey said gases to said user,


wherein said nasal cannula are adapted to deliver said humidified gases to said user, said nasal cannula including at least one prong allowing high flow delivery of said humidified gases and creating positive airway pressure in said patient's airway, said at least one prong having an end that is flared outwardly.


To those skilled in the art to which the invention relates, many changes in construction and widely differing embodiments and applications of the invention will suggest themselves without departing from the scope of the invention as defined in the appended claims. The disclosures and the descriptions herein are purely illustrative and are not intended to be in any sense limiting.





BRIEF DESCRIPTION OF THE DRAWINGS

Preferred forms of the present invention will now be described with reference to the accompanying drawings.



FIG. 1 is a block diagram of a system providing humidified continuous positive airway pressure to a user as might be used in conjunction with a nasal cannula of the present invention.



FIG. 2 is a perspective view of a first embodiment of the nasal cannula of the present invention.



FIG. 3 is a side view of the nasal cannula of FIG. 2.



FIG. 4 is a plan view of the nasal cannula of FIG. 2.



FIG. 5 is a prong end view of the nasal cannula of FIG. 2



FIG. 6 is an exploded view of the nasal cannula of FIG. 2.



FIG. 7 is a side view of a second embodiment of a nasal cannula of the present invention.



FIG. 8 is a side view of a third embodiment of a nasal cannula of the present invention.



FIG. 9 is a perspective view of a fourth embodiment of a nasal cannula of the present invention.



FIG. 10 is a side view of the nasal cannula of FIG. 9.



FIG. 11 is an exploded perspective view of the nasal cannula of FIG. 9.



FIG. 12 is a front view of the prongs of the nasal cannula of FIG. 9.



FIG. 13 is an exploded side view of the nasal cannula of FIG. 9.



FIG. 14 is a side cross-sectional view of a fifth embodiment of the nasal cannula of the present invention where the connection between a body part and connector of the cannula includes a plurality of channels.



FIG. 15 is a cross-section through AA of the nasal cannula of FIG. 14.



FIG. 16 is a side cross-sectional view of a sixth embodiment of the nasal cannula of the present invention including a shield that protects an outlet vent from inlet gases.



FIG. 17 is a cross-section through BB of the nasal cannula of FIG. 16.





DETAILED DESCRIPTION

Whether used in a hospital environment or in a home environment, the nasal cannula of the present invention will generally have associated three main pieces of apparatus. Firstly, an active humidifier, which that controls the temperature of a heater plate heating a body of water to achieve a desired temperature and humidity of the gases being humidified. Secondly, a transport conduit from the humidifier to the patient is also required, which is preferably heated to reduce condensation, or “rain out”. Thirdly, a cannula designed to fit into the nasal cavity and deliver humidified, pressurized gases. In particular, in one embodiment the nasal cannula of the present invention has two flared end prongs that seal within a patient's nares, although in some embodiments the cannula may have a single prong. The cannula prongs are shaped such that a step is created between them so that the prongs abut the user's nasal septum in use. Furthermore, the gripping action of the sides of the prongs to the user's septum in use prevents the prongs from dislodging from the user's nares. In another embodiment the prongs of the nasal cannula are angled toward one another as well as having an angled profile at the outlet of gases, such that gases flow from the prongs flows back into the nasal passage and is not forced up into the rest of the nasal cavity.


With reference to FIG. 1 a humidified Continuous Positive Airway Pressure (CPAP) system is shown in which a patient 1 is receiving humidified and pressurised gases through the nasal cannula 2 of the present invention. The cannula 2 is connected to a humidified gases transportation pathway or inspiratory conduit 3. It should be understood that delivery systems could also be VPAP (Variable Positive Airway Pressure) and BiPAP (Bi-level Positive Airway Pressure) or numerous other forms of respiratory therapy. Inspiratory conduit 3 is connected to the outlet 4 of a humidification chamber 5 that contains a volume of water 6. The inspiratory conduit 3 may contain heating means or heater wires (not shown) which heat the walls of the conduit to reduce condensation of humidified gases within the conduit. The humidification chamber 5 is preferably formed from a plastics material and may have a highly heat conductive base (for example an aluminium base) which is in direct contact with a heater plate 7 of humidifier 8. The humidifier 8 is provided with control means or electronic controller 9 that may comprise a microprocessor based controller executing computer software commands stored in associated memory.


The controller 9 receives input from sources such as user input means or dial 10 through which a user of the device may, for example, set a predetermined required value (preset value) of humidity or temperature of the gases supplied to patient 1. The controller may also receive input from other sources; for example, temperature and/or flow velocity sensors 11 and 12 through connector 13 and heater plate temperature sensor 14. In response to the user set humidity or temperature value input via dial 10 and the other inputs, controller 9 determines when (or to what level) to energise heater plate 7 to heat the water 6 within humidification chamber 5. A flow of gases (for example air) is provided to the chamber through inlet 16 from a gases supply means or blower 15. As the volume of water 6 within humidification chamber 5 is heated, water vapour begins to fill the volume of the chamber above the water's surface and is passed out of the humidification chamber 5 through outlet 4. Exhaled gases from the patient's mouth are passed directly to ambient surroundings in FIG. 1.


The blower 15 is provided with variable pressure regulating means or a variable speed fan 20 which draws air or other gases through the blower inlet 17. The speed of the variable speed fan 20 is controlled by the electronic controller 18 (or alternatively the function of the controller 18 could carried out by the controller 9) in response to inputs from the controller 9 and a user set predetermined required value (preset value) of pressure or fan speed via the dial 19.


Flared Prong Nasal Cannula


A first embodiment of a nasal cannula of the present invention is shown in detail in FIGS. 2 to 6. Referring to FIGS. 2 and 6, the nasal cannula 2 comprises three main components; the prong part 21, body part 22 and ball connector 23.


The prong part 21 has two nasal prongs 24, 25, each of which are substantially shaped to follow the contours of the human nares and in use are placed inside a user's nares. The prongs 24, 25 extend out from a hollow tubular body 26 that in use fits to the body part 22. Each of the prongs 24, 25 are integrally moulded with the tubular body 26 in a flexible plastics material or rubber, such as silicone, other thermoset elastomers or thermoplastic elastomers such as Kraton™. The prongs 24, 25 are substantially oval tubular members that allow for a passage of gases. In particular, as shown in FIG. 5, the prongs are oval in shape and angled in the same manner as a human's nares. The prongs 24, 25 are angled toward one another (or toward the vertical axis Y) at the top 27, 28 of the prongs and away from one another at the bottom 29, 30 of the prongs. Furthermore, the ends 31, 32 of the prongs flare outwardly and preferably are formed such that the ends of the prongs are thinner in cross-section than the rest of the prongs. The flared thinner section ends 31, 32 of the prongs assist with the sealing of the prongs 24, 25 in use within the user's nares. When in use and with gases flowing through the prongs the force of the gas pressure will force the prong ends 31, 32 to flare outwardly and seal against the inside of the user's nares.


The prongs 24, 25 each include a step 33, 34 formed along their lengths. Each of the steps 33, 34 are formed on the prongs 24, 25 in an opposing manner such that in use, when the prongs are within a user's nares the steps 33, 34 abut the user's nasal septum and form a ledge that prevents dislodgement of the prongs. The prongs 24, 25 also have protrusions 35, 36 formed on their outer edges that abut the sides of the user's nares (opposite to the nasal septum). The protrusions 35, 36 assist in preventing the dislodgement of the prongs, especially if the user moves his or her head. The protrusions 35, 36 also maintain the prongs within the user's nares in a correct orientation such that in use gases flow through the prongs and directly up the user's nasal passages.


The body part 22 is a tubular passageway in which the prong part 21 is connected at one end and a ball joint 37 at the other end. The ball joint 37 extends from the connector 23 and slots into a complementary shaped (partial sphere) socket end 39. The body part 22 also has a number of apertures 38 formed in it, which act as a bias flow outlet vent. Therefore, any gases exhaled by the user through their nose will exit through the apertures 38.


The connector 23 is preferably connected to the inspiratory conduit 3 (see FIG. 1) that supplies gases flow to the cannula 2. The inspiratory conduit 3 may be moulded directly to the connector 23 or other connection mechanisms may be used, such as a friction fit formed between the connector and conduit.


Although a ball and socket joint, as described above, between the body part 22 and connector 23 is preferred other connections may be utilised, such as a flexible piece of silicone, or other appropriate connection. The connection between the cannula body and connector must be able to be flexed or rotated to allow for the inspiratory conduit 3 to be moved without causing the dislodgement of the nasal cannula 2 from the user's nares.


In the preferred form of the nasal cannula 2 of the present invention the body part 22 and connector 23 are preferably made from a hard or rigid plastics material, such as polypropylene, polycarbonate or acetyl. In other forms the body part 22 and connector 23 may be of different plastics materials to allow for increased slidability between these parts.


The prong part 21 may be supplied in various different sizes such that different sized user's may remove an existing prong part and simply attach a different sized flexible plastics prong part over the body part 22.


To provide additional comfort for the user or ensure the nasal cannula of the present invention do not fall from a user's nares, the nasal cannula may be used in combination with a headgear strap, which in one embodiment is a small flexible tube. For example, FIG. 1 shows a headgear strap 40 extending from the nasal cannula 2. The ends of the headgear strap that attach to the cannula may attach to extensions (or loops) 41 on the body part 22 of the cannula shown in FIG. 2, or may attach about other appropriate areas of the cannula, for example, about the connector 23.


The abovementioned embodiment of the nasal cannula 2 of the present invention is preferably a wide bore pronged cannula used for high flow conditions.


A second embodiment of the present invention is shown in FIG. 7. In this embodiment of the nasal cannula 42 the prongs 43, 44 are preferably small bore prongs for use with lower flow conditions. The prongs 43, 44 are similarly shaped to the prongs 24, 25 detailed above, but may not seal in the same manner as the abovementioned prongs due to the smaller size of the prongs. In fact these prongs may not seal at all in use within the user's nares.


Furthermore, in this second embodiment the nasal cannula 42 is smaller and weighs less as it is only comprised of a prong body 45 and prongs 43, 44, where the body 45 is connected to a small tube that is formed with corrugations or bellows 48 that connect to an inspiratory tube or conduit 47 (similar to the inspiratory conduit 3 described above) that receives a supply of gases.


The corrugations of bellows 48 will bend or move when a weight or force is placed on the cannula, thereby preventing dislodgement of the cannula 42 from a user's face in use. In particular, the corrugations or bellows 48 prevent transferral of the torque onto the cannula 42 when a user moves his or her head.


The body 45 of the cannula 42 is provided with a number of apertures 46 that allows for gases exhaled by the users to be expelled into the ambient air.


The prong body and prongs of this embodiment of the cannula of the present invention are preferably formed a flexible plastics material or rubber, such as silicone, other thermoset elastomers or thermoplastic elastomers such as Kraton™.


A third embodiment of the nasal cannula of the present invention is shown in FIG. 8 where the cannula may be provided with corrugated or baffled sections on the prongs. The nasal cannula 49 of this embodiment is similar to that of FIG. 2 but the prongs 50, 51 have a series of corrugations 52, 53 formed in them. The corrugations 52, 53 allow for movement of each of the prongs 50, 51 for a better user fit, and allow for movement of the cannula 49 without causing dislodgement of the prongs from the user's nares.


Angled Prong Nasal Cannula


A fourth embodiment of the nasal cannula of the present invention is shown in FIGS. 9 to 13. The nasal cannula 60 has a similar construction to the nasal cannula of FIG. 2 and comprises three main components; a prong part 61, body part 62 and ball jointed connector 63.


The prong part 61 preferably has two nasal prongs 64, 65, each of which are substantially shaped to follow the contours of the human nares and in use are placed inside a user's nares. In some forms a cannula with only one prong may be provided. The prongs 64, 65 extend out from a hollow tubular body 66 that in use fits to the body part 62, preferably about an extension 67 (as shown in the exploded view of the nasal cannula of FIG. 11). Each of the prongs 64, 65 are integrally moulded with the tubular body 66 in a flexible plastics material or rubber, such as silicone, other thermoset elastomers or thermoplastic elastomers, such as Kraton™. The prongs 64, 65 are substantially oval tubular members that allow for a passage of gases.


In particular, as shown in FIG. 12, the prongs are oval in shape (to reflect the shape of human nares) and angled in the same manner as a human's nares. The prongs 64, 65 are angled toward one another (or toward the horizontal axis X) such that angles a are formed between the midlines m, n through each respective prong 64, 65. The angled profile of the prongs 64, 65 means that they are more ergonomically correct with a human's nares and may assist in directing the gases flow from the prongs to the user's nasal cavities. The prongs 64, 65 are constructed such that their cross-sectional width narrows closer to the tip of each prong.


In the preferred form the prongs 64, 65 have an angled and profiled end 76 (see FIG. 10). The angled ends 76 assist in directing gases flow to the user's nasal passages.


Each of the prongs 64, 65 has a flange 73, 74 disposed about its circumference. The flanges 73, 74 are at a position on the prongs 64, 65 such that the each of the flanges rests against the outside of each of the patient's nares. The flanges 73, 74 do not extend inside the nares, but rest at the entranceway of the user's nares, and preferably seal the nares. In some users the flanges 73, 74 may extend within the user's nares and provide sealing of the nares. The flanges 73, 74 are preferably thin flexible extensions that extend substantially completely around the circumference of the prongs 64, 65. The flanges 73, 74 are preferably substantially elliptical in shape with one side (for example, side 89, which in use will abut the nasal septum of a user) of the flange extending out from each prong further than the other side of each prong. There is a recessed area 88 on each of the prongs between the flange and the shaped ends of the prongs in which preferably in use the ends of a user's nares rest.


The body part 62 is a tubular passageway in which the prong part 61 is connected at one end and a ball joint 69 at the other end. The ball joint 69 extends from the connector 63 and slots into a complementary shaped (partial sphere) socket end 70 on the body part 62. The body part 62 may also have a plurality of apertures formed in it, which acts as a bias flow outlet vent 71. Therefore, any gases exhaled by the user through their nose will exit through the apertures.


A shield 75 (illustrated by the dashed line in FIG. 10) may extend over the bias vent 71 inside the body part 62 to prevent gases from the blower (gases supply 15) from interacting with the bias vent 71 and vent holes, causing noise in use.


In a sixth embodiment as shown in FIGS. 16 and 17 a nasal cannula without a prong part is shown, but that includes a shield similar to that described above. In this embodiment a body part 90 and a ball jointed connector 91 fit together as described above. The body part 90 includes an expiratory vent shield 92 that extends down from the top wall 94 of the body part 90 and shields the outlet vent 93.


Referring back to FIGS. 10 to 13, preferably the ball joint connector 63 is angled and extends into a swivelable connector 68. The swivel connector 68 is capable in use of being connected to the inspiratory conduit 3 (see FIG. 1) that supplies gases flow to the cannula 60. The inspiratory conduit 3 may be moulded directly to the connector 68 or other connection mechanisms may be used, such as a friction fit formed between the connector 68 and the conduit 3.


In other forms of the present invention the ball joint connector 63 or the ball joint 69 may have formed in it a plurality of channels. One example of this is the embodiment of FIGS. 14 and 15. Such channels allow there to be a leak when gases flow through the connector to the cannula and prongs. The channels are therefore capable of acting as a bias flow and a separate bias flow out outlet (such as that vent 71 described above) may not be required.


In FIGS. 14 and 15 only a body part 82 and ball jointed connector 83 are shown. The body part 82 and ball jointed connector 83 join in a manner as described above, where the substantially half sphere shaped end 84 of the body part 82 receives the substantially half sphere shaped end 85 of the connector 83. The ends 84, 85 enable a rotation between the body part 82 and connector 83. In this embodiment two channels 86, 87 are formed in the connector end 85. Two channels are shown in this embodiment but there may be only one or any number of channels. Similarly, channels may be formed in the body part end 84.


It is preferred that there is a ball and socket joint, as described above, between the body part 62 and connector 63, although other connections may be utilised, such as a flexible piece of silicone, or other appropriate connection. The connection between the cannula body and connector must be able to be flexed or rotated to allow for the inspiratory conduit 3 to be moved without causing the dislodgement of the nasal cannula 60 from the user's nares.


In the preferred form of the nasal cannula 60 of the present invention the body part 62, connector 63, ball joint 69 and swivel connector 68 are preferably made from a hard or rigid plastics material, such as polypropylene, polycarbonate or acetyl. In other forms these may be of different plastics materials to allow for increased slidability between these parts.


The prong part 61 may be supplied in various different sizes such that different sized user's may remove an existing prong part and simply attach a different sized flexible plastics prong part over the body part 62.


To provide additional comfort for the user or ensure the nasal cannula of the present invention does not fall from a user's nares, the nasal cannula 60 is preferably used in combination with a headgear strap. The strap may be similar to that shown in FIG. 1 with relation to the first form of the nasal cannula 2. In this fourth form of the nasal cannula 60 the body part 62 has headgear extensions 72, 73 that extend out from the body part 62. The extensions 72, 73 each have a channel 77, 78 formed in them that is capable of receiving an end 80, 81 of the headgear strap 79. The strap ends 80, 81 in use are threaded through apertures (preferably two) and extend into and are held in the channels 77, 78. In this form the headgear strap 79 is made from a small diameter silicon, rubber or similar type material. Therefore, when the strap ends 80, 81 are threaded through the apertures friction is created that maintains the straps within the apertures and prevents the straps from slipping from the cannula.


In other forms the ends of the headgear strap that attach to the cannula may attach to extensions (or loops) 41 on the body part 22 of the cannula shown in FIG. 6, or may attach about other appropriate areas of the cannula, for example, about the connector 23.

Claims
  • 1. A mask assembly for delivering positive airway pressure to a user in use, wherein a distal direction extends away from the user in use and a proximal direction extends toward the use in use, the mask assembly comprising: a seal member comprising a seal member distal end with a first opening and a seal member proximal end with at least a second opening, the first opening configured to receive a flow of pressurized gases and the seal member proximal end being configured to seal against the user in use and provide a flow of pressurized gases to the user;a body part comprising a distal portion, a proximal portion, and a bias flow vent, the distal portion including a connector end with a connector end opening, the proximal portion including a seal member end with a seal member opening, the body part defining a tubular passageway fluidly connecting the seal member opening with the connector end opening, the bias flow vent comprising a plurality of vent holes configured to vent gases exhaled by the user in use, from an interior of the body part to an exterior of the body part;a partially spherical connector comprising a partially spherical end and a swivelable end, wherein the partially spherical end slots into the connector end of the body part and allows rotation between the partially spherical connector and the body part, and wherein the swivelable end is configured to connect to an inspiratory conduit configured to deliver a pressurized flow of gases into the partially spherical connector; andan expiratory vent shield extending from an interior position in the body part between the connector end and the seal member end on a proximal side of the connector end, the expiratory vent shield comprising a first end and a second end positioned closer to the user in use than the first end, the expiratory vent shield extending from the interior position in the body part on the proximal side of the connector end and the partially spherical connector, along the proximal direction, toward the seal member end of the body part with the second end positioned closer to the user than the first end, in use, the expiratory vent shield comprising a curved portion extending into the flow of pressurized gases.
  • 2. The mask assembly of claim 1, wherein the connector end and the partially spherical end form a ball joint assembly.
  • 3. The mask assembly of claim 1, wherein the expiratory vent shield prevents gases from a blower from interacting with the plurality of vent holes of the bias flow vent.
  • 4. A mask assembly for delivering positive airway pressure to a user in use, the mask assembly comprising: a seal member configured to seal against a user in use, the seal member comprising a distal end with a first opening and a proximal end with at least a second opening;a body part comprising a distal portion, a proximal portion, and a bias flow vent, the distal portion including a connector end with a connector end opening, the proximal portion including a seal member end with a seal member opening, the body part defining a tubular passageway having an inner surface and fluidly connecting the connector end opening with the seal member opening, the connector end comprising a partially spherical socket, the bias flow vent configured to vent gases exhaled by the user in use to an exterior of the body part;a partially spherical connector comprising a swivelable end and a partially spherical end disposed within the partially spherical socket; andan expiratory vent shield comprising a distalfirst end and a second end, the first end being positioned on a proximal side of the connector end and the partially spherical connector, the second end positioned closer to the user in use than the first end, the expiratory vent shield extending from the first end toward the second end, away from the inner surface of the tubular passageway and proximally toward the user in use and proximally beyond the partially spherical end.
  • 5. The mask assembly of claim 4, wherein the partially spherical socket and the partially spherical end form a ball joint assembly configured to allow rotation between the partially spherical connector and the body part.
  • 6. The mask assembly of claim 4, wherein the expiratory vent shield extends into and narrows the tubular passageway defined by the body part.
  • 7. The mask assembly of claim 4, wherein the swivelable end is configured to be connected to an inspiratory conduit configured to deliver a flow of pressurized gases into the body part and the seal member for inhalation by a user in use.
  • 8. The mask assembly of claim 4, wherein the expiratory vent shield comprises a curved portion and a straight portion.
  • 9. The mask assembly of claim 8, wherein the straight portion and the curved portion are continuous with each other.
  • 10. The mask assembly of claim 4, wherein the partially spherical socket comprises a partially spherical socket surface that extends circumferentially around the connector end opening and wherein the first end of the expiratory vent shield extends from the partially spherical socket surface.
  • 11. An airway passage assembly for a positive airway pressure mask, the airway passage assembly comprising: a body part comprising a distal portion, a proximal portion, and a bias flow vent, the distal portion including a connector end with a connector end opening, the proximal portion including a seal member end with a seal member opening, a tubular passageway connecting the connector end opening with seal member opening, the bias flow vent configured to vent gases exhaled by a user in use to an exterior of the body part, the connector end opening comprising a partially spherical socket configured to receive a partially spherical connector; andan expiratory vent shield extending from an interior of the body part and disposed between the connector end opening and the bias flow vent, the expiratory vent shield comprising a proximal end disposed proximally closer to the user than the partially spherical socket, in use, wherein at least a portion of the expiratory vent shield is spaced proximally from the connector end and spaced distally from the seal member end.
  • 12. The airway passage assembly of claim 11, wherein the expiratory vent shield divides a portion of a tubular passageway defined by the body part into an inspiratory flow path and an expiratory flow path.
  • 13. The airway passage assembly of claim 11, wherein the expiratory vent shield defines a narrowed portion of the tubular passageway.
  • 14. The airway passage assembly of claim 11, wherein the connector end opening comprises a partially spherical socket configured to receive a partially spherical connector so as to allow for rotation therebetween.
  • 15. The airway passage assembly of claim 11, additionally comprising a partially spherical connector having a partially spherical end portion configured to slot into the connector end opening and a swivel end configured to be connectable to an inspiratory conduit.
  • 16. The airway passage assembly of claim 11, wherein the expiratory vent shield comprises a curved portion and a straight portion.
  • 17. The airway passage assembly of claim 16, wherein the straight portion and the curved portion are continuous with each other.
  • 18. The airway passage assembly of claim 11, wherein the connector end opening comprises a partially spherical socket surface that extends circumferentially around the connector end opening.
  • 19. The airway passage assembly of claim 18, additionally comprising a connector comprising a swivelable end and a partially spherical end disposed within the partially spherical socket, wherein the proximal end of the expiratory vent shield is disposed proximally closer to the user than the partially spherical end of the connector in use.
  • 20. The airway passage assembly of claim 19, wherein the body part defines the tubular passageway.
Priority Claims (2)
Number Date Country Kind
531332 Feb 2004 NZ national
534606 Aug 2004 NZ national
US Referenced Citations (631)
Number Name Date Kind
301111 Genese Jul 1884 A
472238 Van Orden Apr 1892 A
577926 Miller Mar 1897 A
718470 Jones Jan 1903 A
751091 Moran Feb 1904 A
770013 Linn Sep 1904 A
1635545 Drager Jul 1927 A
2126755 Dreyfus Aug 1938 A
2228218 Schwartz Jan 1941 A
2241535 Boothby et al. May 1941 A
2296150 Dockson et al. Sep 1942 A
2353643 Bulbulian Jul 1944 A
2359506 Battley et al. Oct 1944 A
2388604 Eisenbud Nov 1945 A
2452845 Fisher Nov 1948 A
2508050 Valente May 1950 A
2684066 Glidden Jul 1954 A
2693800 Caldwell Nov 1954 A
2738788 Matheson et al. Mar 1956 A
2843121 Hudson Jul 1958 A
2859748 Hudson Nov 1958 A
2875759 Galleher Mar 1959 A
2894506 Rose Jul 1959 A
2939458 Lundquist Jun 1960 A
3424633 Corrigall et al. Jan 1969 A
3490452 Greenfield Jan 1970 A
3599635 Kenneth Aug 1971 A
3682171 Dali et al. Aug 1972 A
3834682 McPhee Sep 1974 A
3850171 Ball et al. Nov 1974 A
3894562 Mosley et al. Jul 1975 A
3972321 Proctor Aug 1976 A
3977432 Vidal Aug 1976 A
3992720 Nicolinas Nov 1976 A
4090510 Segersten May 1978 A
D250047 Lewis et al. Oct 1978 S
D250131 Lewis et al. Oct 1978 S
4127130 Naysmith Nov 1978 A
4150464 Tracy Apr 1979 A
D252322 Johnson Jul 1979 S
4201205 Bartholomew May 1980 A
4258710 Reber Mar 1981 A
4266540 Panzik et al. May 1981 A
4278082 Blackmer Jul 1981 A
4354488 Bartos Oct 1982 A
4367735 Dali Jan 1983 A
4378011 Warncke et al. Mar 1983 A
4437462 Piljay Mar 1984 A
4454880 Muto et al. Jun 1984 A
4574799 Warncke Mar 1986 A
4603602 Montesi Aug 1986 A
4621632 Bartels et al. Nov 1986 A
4644974 Zingg Feb 1987 A
4676241 Webb et al. Jun 1987 A
D293613 Wingler Jan 1988 S
4753233 Grimes Jun 1988 A
4782832 Trimble et al. Nov 1988 A
4803981 Vickery Feb 1989 A
4804160 Harbeke Feb 1989 A
4836200 Clark et al. Jun 1989 A
4856508 Tayebi Aug 1989 A
4907584 McGinnis Mar 1990 A
4915104 Marcy Apr 1990 A
4915105 Lee Apr 1990 A
4919128 Kopala et al. Apr 1990 A
4938209 Fry Jul 1990 A
4941467 Takata Jul 1990 A
4944310 Sullivan Jul 1990 A
D310431 Bellm Sep 1990 S
4958658 Zajac Sep 1990 A
4971051 Toffolon Nov 1990 A
4986269 Hakkinen Jan 1991 A
5010925 Atkinson et al. Apr 1991 A
5016625 Hsu et al. May 1991 A
5031261 Fenner Jul 1991 A
5042478 Kopala et al. Aug 1991 A
D320677 Kumagai et al. Oct 1991 S
D321419 Wallace Nov 1991 S
5062421 Burns et al. Nov 1991 A
5065756 Rapoport Nov 1991 A
D322318 Sullivan et al. Dec 1991 S
5074297 Venegas Dec 1991 A
5094236 Tayebi Mar 1992 A
5113857 Dickerman et al. May 1992 A
5121745 Israel et al. Jun 1992 A
5148802 Sanders et al. Sep 1992 A
5164652 Johnson et al. Nov 1992 A
5231979 Rose Aug 1993 A
5243971 Sullivan et al. Sep 1993 A
5245995 Sullivan et al. Sep 1993 A
D340317 Cole Oct 1993 S
5259377 Schroeder Nov 1993 A
5267556 Feng Dec 1993 A
5269296 Landis et al. Dec 1993 A
5315859 Schommer May 1994 A
5349949 Schegerin Sep 1994 A
5366805 Fujiki et al. Nov 1994 A
D354128 Rinehart Jan 1995 S
D355484 Rinehart Feb 1995 S
5400776 Bartholomew Mar 1995 A
5429683 Le Mitouard Jul 1995 A
5438979 Johnson et al. Aug 1995 A
5441046 Starr et al. Aug 1995 A
5449206 Lockwood Sep 1995 A
5449234 Gipp et al. Sep 1995 A
5458202 Fellows et al. Oct 1995 A
5460174 Chang Oct 1995 A
5461932 Hall Oct 1995 A
5477852 Landis et al. Dec 1995 A
5513634 Jackson May 1996 A
5518802 Colvin et al. May 1996 A
5533506 Wood Jul 1996 A
5540223 Starr et al. Jul 1996 A
5542128 Lomas Aug 1996 A
5551419 Froehlich et al. Sep 1996 A
5558090 James Sep 1996 A
5560354 Berthon-Jones et al. Oct 1996 A
5570689 Starr et al. Nov 1996 A
5588423 Smith Dec 1996 A
5595174 Gwaltney Jan 1997 A
5601078 Schaller et al. Feb 1997 A
D378610 Reischel et al. Mar 1997 S
5649532 Griffiths Jul 1997 A
5657752 Landis et al. Aug 1997 A
5662101 Ogden et al. Sep 1997 A
5664566 Mcdonald et al. Sep 1997 A
5687715 Landis Nov 1997 A
5690097 Howard et al. Nov 1997 A
5724677 Bryant et al. Mar 1998 A
5724965 Handke et al. Mar 1998 A
5752510 Goldstein May 1998 A
5755578 Corrtant et al. May 1998 A
5789660 Kofoed et al. Aug 1998 A
5806727 Joseph Sep 1998 A
5807295 Hutcheon et al. Sep 1998 A
5746201 Kidd Dec 1998 A
5857460 Popitz Jan 1999 A
5884624 Barnett et al. Mar 1999 A
5904278 Barlow et al. May 1999 A
5918598 Belfer Jul 1999 A
5921239 McCall et al. Jul 1999 A
5924420 Reischel Jul 1999 A
5941245 Hannah et al. Aug 1999 A
5943473 Levine Aug 1999 A
5953763 Gouget Sep 1999 A
5966745 Schwartz et al. Oct 1999 A
6016804 Gleason et al. Jan 2000 A
6017315 Starr et al. Jan 2000 A
6019101 Cotner et al. Feb 2000 A
6021528 Jurga Feb 2000 A
6039044 Sullivan Mar 2000 A
6050260 Daniell et al. Apr 2000 A
6112746 Kwok et al. Sep 2000 A
6116235 Walters et al. Sep 2000 A
6119693 Kwok Sep 2000 A
6119694 Correa et al. Sep 2000 A
6135109 Blasdell et al. Oct 2000 A
6135432 Hebblewhite et al. Oct 2000 A
6192886 Rudolph Feb 2001 B1
D440302 Wolfe Apr 2001 S
6272933 Gradon et al. Aug 2001 B1
6298850 Raves Oct 2001 B1
6302105 Wickham et al. Oct 2001 B1
6341606 Bordewick et al. Jan 2002 B1
6347631 Hansen et al. Feb 2002 B1
D455891 Biedrzycki Apr 2002 S
6398197 Dickinson et al. Jun 2002 B1
6412487 Gunaratnam et al. Jul 2002 B1
6412488 Barnett Jul 2002 B1
6418928 Bordewick et al. Jul 2002 B1
6427694 Hecker et al. Aug 2002 B1
6431172 Bordewick Aug 2002 B1
6435181 Jones, Jr. et al. Aug 2002 B1
6439234 Curti et al. Aug 2002 B1
6457473 Brostrom et al. Oct 2002 B1
6467483 Kopacko et al. Oct 2002 B1
6470886 Jestrabek-Hart Oct 2002 B1
6478026 Wood Nov 2002 B1
6484725 Chi et al. Nov 2002 B1
6488664 Solomon et al. Dec 2002 B1
6491034 Gunaratnam et al. Dec 2002 B1
6513526 Kwok et al. Feb 2003 B2
6526978 Dominguez Mar 2003 B2
6530373 Patron et al. Mar 2003 B1
6561188 Ellis May 2003 B1
6561190 Kwok May 2003 B1
6561191 Kwok May 2003 B1
6571798 Thornton Jun 2003 B1
6581594 Drew et al. Jun 2003 B1
6581601 Ziaee Jun 2003 B2
6581602 Kwok et al. Jun 2003 B2
6584977 Serowski Jul 2003 B1
6588424 Bardel Jul 2003 B2
6615832 Chen Sep 2003 B1
6629531 Gleason et al. Oct 2003 B2
6631718 Lovell Oct 2003 B1
6634358 Kwok et al. Oct 2003 B2
6637434 Noble Oct 2003 B2
6644315 Ziaee Nov 2003 B2
6651658 Hill et al. Nov 2003 B1
6651663 Barnett et al. Nov 2003 B2
6659102 Sico Dec 2003 B1
6662803 Gradon et al. Dec 2003 B2
6668828 Figley et al. Dec 2003 B1
D485905 Moore Jan 2004 S
6679257 Robertson et al. Jan 2004 B1
6679265 Strickland et al. Jan 2004 B2
6691707 Gunaratnam Feb 2004 B1
6712072 Lang Mar 2004 B1
6736139 Wix May 2004 B1
6772761 Rucker, Jr. Aug 2004 B1
6796308 Gunaratnam et al. Sep 2004 B2
6817362 Gelinas et al. Nov 2004 B2
6823869 Raje et al. Nov 2004 B2
6851425 Jaffre et al. Feb 2005 B2
6851428 Dennis Feb 2005 B2
6883177 Ouellette et al. Apr 2005 B1
6892729 Smith et al. May 2005 B2
6895965 Scarberry et al. May 2005 B2
6907882 Ging et al. Jun 2005 B2
6918390 Lithgow et al. Jul 2005 B2
6951218 Gradon et al. Oct 2005 B2
6953354 Edirisuriya et al. Oct 2005 B2
6997187 Wood et al. Feb 2006 B2
7004165 Salcido Feb 2006 B1
7007696 Palkon et al. Mar 2006 B2
7021311 Gunaratnam et al. Apr 2006 B2
D520140 Chaggares May 2006 S
7051765 Kelley et al. May 2006 B1
7066179 Eaton et al. Jun 2006 B2
7077126 Kummer et al. Jul 2006 B2
D526094 Chen Aug 2006 S
7096864 Mayer et al. Aug 2006 B1
D533269 McAuley et al. Dec 2006 S
7178525 Matula, Jr. et al. Feb 2007 B2
7178528 Lau Feb 2007 B2
7201169 Wilkie et al. Apr 2007 B2
7207333 Tohara Apr 2007 B2
7210481 Lovell et al. May 2007 B1
7219669 Lovell et al. May 2007 B1
7225811 Ruiz et al. Jun 2007 B2
7255106 Gallem et al. Aug 2007 B2
7261104 Keifer Aug 2007 B2
7287528 Ho et al. Oct 2007 B2
7290546 Sprinkle et al. Nov 2007 B2
7296575 Radney Nov 2007 B1
7318437 Gunaratnam et al. Jan 2008 B2
7353827 Geist Apr 2008 B2
7357136 Ho et al. Apr 2008 B2
7406966 Wondka et al. Aug 2008 B2
7448386 Ho et al. Nov 2008 B2
7487772 Ging et al. Feb 2009 B2
7493902 White et al. Feb 2009 B2
D589139 Guney Mar 2009 S
7523754 Lithgow et al. Apr 2009 B2
D595841 McAuley et al. Jul 2009 S
7562658 Madaus et al. Jul 2009 B2
7597100 Ging Oct 2009 B2
7640934 Zollinger et al. Jan 2010 B2
7658189 Davidson et al. Feb 2010 B2
7665464 Kopacko et al. Feb 2010 B2
D612933 Prentice Mar 2010 S
7681575 Wixey et al. Mar 2010 B2
7694677 Tang Apr 2010 B2
7703457 Barnett et al. Apr 2010 B2
7708017 Davidson May 2010 B2
7753051 Burrow et al. Jul 2010 B2
D623288 Lubke Sep 2010 S
7814911 Bordewick et al. Oct 2010 B2
7827990 Melidis et al. Nov 2010 B1
7856982 Matula et al. Dec 2010 B2
7877817 Ho Feb 2011 B1
7896003 Matula et al. Mar 2011 B2
7931024 Ho et al. Apr 2011 B2
7934501 Fu May 2011 B2
7942150 Guney May 2011 B2
7992560 Burton et al. Aug 2011 B2
8042539 Chandran et al. Oct 2011 B2
8042541 Amarasinghe et al. Oct 2011 B2
8109271 Vandine et al. Feb 2012 B2
8136524 Ging et al. Mar 2012 B2
8136525 Lubke et al. Mar 2012 B2
8171933 Xue et al. May 2012 B2
D661796 Andrews et al. Jun 2012 S
8245711 Matula et al. Aug 2012 B2
8371302 Ging et al. Feb 2013 B2
8397727 Ng et al. Mar 2013 B2
8443807 McAuley et al. May 2013 B2
D686313 Matula et al. Jul 2013 S
8479726 McAuley Jul 2013 B2
8479741 McAuley et al. Jul 2013 B2
8567404 Davidson et al. Oct 2013 B2
8631793 Omura et al. Jan 2014 B2
8631799 Davenport Jan 2014 B2
8636005 Gradon et al. Jan 2014 B2
8701667 Ho et al. Apr 2014 B1
8714157 McAuley et al. May 2014 B2
8720444 Chang May 2014 B2
8757157 Price et al. Jun 2014 B2
8783257 McAuley et al. Jul 2014 B2
8869797 Davidson et al. Oct 2014 B2
8869798 Wells et al. Oct 2014 B2
8875709 Davidson et al. Nov 2014 B2
8944061 D'Souza et al. Feb 2015 B2
8950404 Formica et al. Feb 2015 B2
8960196 Henry Feb 2015 B2
9010331 Lang et al. Apr 2015 B2
9027556 Ng et al. May 2015 B2
9032955 Lubke et al. May 2015 B2
9032956 Scheiner et al. May 2015 B2
9072852 McAuley et al. Jul 2015 B2
9095673 Barlow et al. Aug 2015 B2
9119929 McAuley et al. Sep 2015 B2
9119931 D'Souza et al. Sep 2015 B2
9138555 McAuley et al. Sep 2015 B2
9149596 Valcic et al. Oct 2015 B2
9186474 Rollins Nov 2015 B1
9242062 Melidis et al. Jan 2016 B2
9292799 McAuley et al. Mar 2016 B2
9295799 McAuley et al. Mar 2016 B2
9302065 Smith Apr 2016 B2
9320566 Alston, Jr. Apr 2016 B1
9320866 McAuley et al. Apr 2016 B2
9333315 McAuley et al. May 2016 B2
9339622 McAuley et al. May 2016 B2
9339624 McAuley May 2016 B2
9375545 Darkin et al. Jun 2016 B2
9381316 Ng et al. Jul 2016 B2
9457162 Ging et al. Oct 2016 B2
9486601 Stallard et al. Nov 2016 B2
9517317 McAuley et al. Dec 2016 B2
9522246 Frater et al. Dec 2016 B2
9539405 McAuley et al. Jan 2017 B2
9550038 McAuley et al. Jan 2017 B2
9561338 McAuley et al. Feb 2017 B2
9561339 McAuley et al. Feb 2017 B2
9744385 Henry et al. Aug 2017 B2
9884160 McAuley et al. Feb 2018 B2
9901699 Veliss et al. Feb 2018 B2
9901700 McAuley et al. Feb 2018 B2
9907925 McAuley et al. Mar 2018 B2
9974914 McAuley May 2018 B2
10080856 McLaren et al. Sep 2018 B2
10137271 McAuley et al. Nov 2018 B2
10201678 Guney Feb 2019 B2
10252015 McAuley et al. Apr 2019 B2
10258756 Mainusch et al. Apr 2019 B2
10258757 Allan et al. Apr 2019 B2
10272218 McAuley et al. Apr 2019 B2
10328226 Allan et al. Jun 2019 B2
10363387 Allan et al. Jul 2019 B2
10384029 McAuley et al. Aug 2019 B2
10413694 Allan et al. Sep 2019 B2
10842964 McAuley Nov 2020 B2
10980962 McAuley Apr 2021 B2
20010017134 Bahr Aug 2001 A1
20010020474 Hecker et al. Sep 2001 A1
20010029952 Curran Oct 2001 A1
20020005198 Kwok et al. Jan 2002 A1
20020014241 Gradon et al. Feb 2002 A1
20020020416 Namey Feb 2002 A1
20020026934 Lithgow et al. Mar 2002 A1
20020029780 Frater et al. Mar 2002 A1
20020039867 Curro et al. Apr 2002 A1
20020046755 Voss Apr 2002 A1
20020053347 Ziaee May 2002 A1
20020059935 Wood May 2002 A1
20020069467 Immediato et al. Jun 2002 A1
20020096176 Gunaratnam et al. Jul 2002 A1
20020096178 Ziaee Jul 2002 A1
20020100474 Kellner et al. Aug 2002 A1
20020100479 Scarberry et al. Aug 2002 A1
20020108613 Gunaratnam et al. Aug 2002 A1
20030005509 Kelzer Jan 2003 A1
20030005931 D. Jaffre Jan 2003 A1
20030005933 Izuchukwu Jan 2003 A1
20030019495 Palkon et al. Jan 2003 A1
20030019496 Kopacko et al. Jan 2003 A1
20030029454 Gelinas et al. Feb 2003 A1
20030047185 Olsen et al. Mar 2003 A1
20030075180 Raje Apr 2003 A1
20030075182 Heidmann et al. Apr 2003 A1
20030079749 Strickland et al. May 2003 A1
20030084996 Alberg et al. May 2003 A1
20030089373 Gradon et al. May 2003 A1
20030094177 Smith May 2003 A1
20030121519 Estes et al. Jul 2003 A1
20030149384 Davis et al. Aug 2003 A1
20030164170 Drew et al. Sep 2003 A1
20030172936 Wilkie et al. Sep 2003 A1
20030196655 Ging et al. Oct 2003 A1
20030196656 Moore Oct 2003 A1
20030196658 Ging et al. Oct 2003 A1
20030196659 Gradon et al. Oct 2003 A1
20030196664 Jacobson Oct 2003 A1
20030200970 Stenzler Oct 2003 A1
20030217746 Gradon et al. Nov 2003 A1
20030221691 Biener Dec 2003 A1
20040011087 Rebouillat et al. Jan 2004 A1
20040025882 Madaus et al. Feb 2004 A1
20040035427 Bordewick et al. Feb 2004 A1
20040065328 Amarasinghe et al. Apr 2004 A1
20040067333 Amarasinghe Apr 2004 A1
20040092999 Lojewski May 2004 A1
20040094157 Dantanarayana et al. May 2004 A1
20040107968 Griffiths Jun 2004 A1
20040112377 Amarasinghe et al. Jun 2004 A1
20040112384 Lithgow et al. Jun 2004 A1
20040112385 Drew Jun 2004 A1
20040118212 Orr et al. Jun 2004 A1
20040118406 Lithgow Jun 2004 A1
20040118412 Piletti-Reyes Jun 2004 A1
20040139973 Wright Jul 2004 A1
20040149280 Semeniuk Aug 2004 A1
20040182398 Sprinkle et al. Sep 2004 A1
20040211427 Jones et al. Oct 2004 A1
20040221850 Ging et al. Nov 2004 A1
20040226566 Gunaratnam et al. Nov 2004 A1
20040255949 Lang et al. Dec 2004 A1
20040261797 White et al. Dec 2004 A1
20050011521 Sprinkle et al. Jan 2005 A1
20050011524 Thomlinson et al. Jan 2005 A1
20050016532 Farrell Jan 2005 A1
20050028822 Sleeper et al. Feb 2005 A1
20050028833 Vena et al. Feb 2005 A1
20050033247 Thompson Feb 2005 A1
20050045182 Wood et al. Mar 2005 A1
20050051171 Booth Mar 2005 A1
20050051177 Wood Mar 2005 A1
20050066976 Wondka Mar 2005 A1
20050076913 Ho et al. Apr 2005 A1
20050092327 Fini et al. May 2005 A1
20050098183 Nash et al. May 2005 A1
20050121037 Wood Jun 2005 A1
20050133038 Rutter Jun 2005 A1
20050150497 Eifler et al. Jul 2005 A1
20050155604 Ging et al. Jul 2005 A1
20050172969 Ging Aug 2005 A1
20050199239 Lang et al. Sep 2005 A1
20050199242 Matula et al. Sep 2005 A1
20050205096 Matula Sep 2005 A1
20050235999 Wood et al. Oct 2005 A1
20050241644 Guney et al. Nov 2005 A1
20060032504 Burton et al. Feb 2006 A1
20060042629 Geist Mar 2006 A1
20060042632 Bishop Mar 2006 A1
20060054169 Han et al. Mar 2006 A1
20060060200 Ho et al. Mar 2006 A1
20060076019 Ho Apr 2006 A1
20060081250 Bordewick et al. Apr 2006 A1
20060081256 Palmer Apr 2006 A1
20060096598 Ho et al. May 2006 A1
20060102185 Drew et al. May 2006 A1
20060107958 Sleeper May 2006 A1
20060118117 Berthon-Jones et al. Jun 2006 A1
20060124131 Chandran Jun 2006 A1
20060130844 Ho et al. Jun 2006 A1
20060137690 Gunaratnam et al. Jun 2006 A1
20060169286 Eifler et al. Aug 2006 A1
20060174887 Chandran et al. Aug 2006 A1
20060196511 Lau et al. Sep 2006 A1
20060201514 Jones et al. Sep 2006 A1
20060207599 Busch Sep 2006 A1
20060225740 Eaton et al. Oct 2006 A1
20060231103 Matula et al. Oct 2006 A1
20060237017 Davidson et al. Oct 2006 A1
20060237018 McAuley et al. Oct 2006 A1
20060249159 Ho Nov 2006 A1
20060254593 Chang Nov 2006 A1
20060266361 Hernandez Nov 2006 A1
20060283458 Woodard Dec 2006 A1
20060283459 Geiselhart et al. Dec 2006 A1
20060283461 Lubke et al. Dec 2006 A1
20070000492 Hansel et al. Jan 2007 A1
20070010786 Casey et al. Jan 2007 A1
20070044804 Matula et al. Mar 2007 A1
20070062536 McAuley Mar 2007 A1
20070089749 Ho et al. Apr 2007 A1
20070107733 Ho May 2007 A1
20070125384 Zollinger et al. Jun 2007 A1
20070125385 Ho et al. Jun 2007 A1
20070125387 Zollinger et al. Jun 2007 A1
20070137653 Wood Jun 2007 A1
20070142785 Lundgaard et al. Jun 2007 A1
20070157353 Guney et al. Jul 2007 A1
20070163594 Ho et al. Jul 2007 A1
20070163600 Hoffman Jul 2007 A1
20070174952 Jacob Aug 2007 A1
20070175480 Gradon et al. Aug 2007 A1
20070209663 Marque et al. Sep 2007 A1
20070215161 Frater et al. Sep 2007 A1
20070221227 Ho Sep 2007 A1
20070227541 Van Den Oct 2007 A1
20070272249 Chandran Nov 2007 A1
20070295335 Nashed Dec 2007 A1
20080035152 Ho et al. Feb 2008 A1
20080041388 McAuley et al. Feb 2008 A1
20080041393 Bracken Feb 2008 A1
20080047560 Veliss et al. Feb 2008 A1
20080053450 Van Kerkwyk et al. Mar 2008 A1
20080060648 Thornton et al. Mar 2008 A1
20080060653 Hallett et al. Mar 2008 A1
20080060657 McAuley et al. Mar 2008 A1
20080083412 Henry et al. Apr 2008 A1
20080092905 Gunaratnam Apr 2008 A1
20080099024 Gunaratnam et al. May 2008 A1
20080105257 Klasek et al. May 2008 A1
20080110464 Davidson et al. May 2008 A1
20080135050 Hitchcock et al. Jun 2008 A1
20080142019 Lewis Jun 2008 A1
20080149104 Eifler Jun 2008 A1
20080171737 Fensorne Jul 2008 A1
20080178875 Henry Jul 2008 A1
20080178886 Lieberman et al. Jul 2008 A1
20080190432 Blochlinger et al. Aug 2008 A1
20080190436 Jaffe et al. Aug 2008 A1
20080196728 Ho Aug 2008 A1
20080210241 Schulz et al. Sep 2008 A1
20080223370 Kim Sep 2008 A1
20080236586 Mcdonald et al. Oct 2008 A1
20080257354 Davidson Oct 2008 A1
20080264422 Fishman Oct 2008 A1
20080271739 Facer et al. Nov 2008 A1
20080276937 Davidson et al. Nov 2008 A1
20080302366 McGinnis et al. Dec 2008 A1
20080314388 Brambilla et al. Dec 2008 A1
20080314390 Kwok et al. Dec 2008 A1
20080319334 Yamamori Dec 2008 A1
20090014007 Brambilla Jan 2009 A1
20090032024 Burz Feb 2009 A1
20090044808 Guney Feb 2009 A1
20090078267 Burz et al. Mar 2009 A1
20090107504 McAuley et al. Apr 2009 A1
20090114227 Gunaratnam et al. May 2009 A1
20090120442 Ho May 2009 A1
20090126739 Ng et al. May 2009 A1
20090133697 Kwok et al. May 2009 A1
20090139527 Ng et al. Jun 2009 A1
20090145429 Ging et al. Jun 2009 A1
20090151729 Judson et al. Jun 2009 A1
20090173349 Hernandez et al. Jul 2009 A1
20090183734 Kwok et al. Jul 2009 A1
20090183739 Wondka Jul 2009 A1
20090211583 Carroll et al. Aug 2009 A1
20090223519 Eifler et al. Sep 2009 A1
20090320842 Doherty Dec 2009 A1
20100000538 Edwards et al. Jan 2010 A1
20100000539 Woodard Jan 2010 A1
20100000543 Berthon-Jones et al. Jan 2010 A1
20100051031 Lustenberger et al. Mar 2010 A1
20100051034 Howard Mar 2010 A1
20100083969 Crumblin Apr 2010 A1
20100108072 D'Souza May 2010 A1
20100132717 Davidson et al. Jun 2010 A1
20100154798 Henry et al. Jun 2010 A1
20100170516 Grane Jul 2010 A1
20100199992 Ho Aug 2010 A1
20100229868 Rummery et al. Sep 2010 A1
20100229872 Ho Sep 2010 A1
20100258132 Moore Oct 2010 A1
20100258136 Doherty et al. Oct 2010 A1
20100294281 Ho Nov 2010 A1
20100307502 Rummery et al. Dec 2010 A1
20100313891 Veliss et al. Dec 2010 A1
20100319700 Ng et al. Dec 2010 A1
20100326445 Veliss et al. Dec 2010 A1
20110067704 Kooij Mar 2011 A1
20110072553 Ho Mar 2011 A1
20110088699 Skipper Apr 2011 A1
20110126838 Alberici Jun 2011 A1
20110146685 Allan et al. Jun 2011 A1
20110162654 Carroll et al. Jul 2011 A1
20110232649 Collazo et al. Sep 2011 A1
20110259337 Hitchcock et al. Oct 2011 A1
20110265796 Amarasinghe et al. Nov 2011 A1
20110290253 McAuley Dec 2011 A1
20120125339 Ho et al. May 2012 A1
20120132208 Judson et al. May 2012 A1
20120132209 Rummery May 2012 A1
20120138061 Dravitzki et al. Jun 2012 A1
20120204879 Cariola et al. Aug 2012 A1
20120285457 Mansour et al. Nov 2012 A1
20120304999 Swift et al. Dec 2012 A1
20120318265 Amirav et al. Dec 2012 A1
20130133659 Ng et al. May 2013 A1
20130133664 Startare May 2013 A1
20130152918 Rummery et al. Jun 2013 A1
20130160769 Ng et al. Jun 2013 A1
20140026888 Matula Jan 2014 A1
20140083428 Rothermel et al. Mar 2014 A1
20140083430 Matula, Jr. et al. Mar 2014 A1
20140137870 Barlow et al. May 2014 A1
20140261432 Eves et al. Sep 2014 A1
20140311492 Stuebiger et al. Oct 2014 A1
20140338672 D'Souza et al. Nov 2014 A1
20150033457 Tryner et al. Feb 2015 A1
20150090266 Melidis et al. Apr 2015 A1
20150246198 Bearne et al. Sep 2015 A1
20150335846 Romagnoli et al. Nov 2015 A1
20150352308 Cullen Dec 2015 A1
20150374944 Edwards et al. Dec 2015 A1
20160001028 McAuley et al. Jan 2016 A1
20160008558 Huddart et al. Jan 2016 A1
20160015922 Chodkowski et al. Jan 2016 A1
20160038707 Allan et al. Feb 2016 A1
20160051786 McAuley et al. Feb 2016 A1
20160213873 McAuley et al. Jul 2016 A1
20160213874 Davidson et al. Jul 2016 A1
20160296720 Henry et al. Oct 2016 A1
20170028148 McAuley et al. Feb 2017 A1
20170143925 McAuley et al. May 2017 A1
20170239438 McAuley et al. Aug 2017 A1
20170246411 Mashal et al. Aug 2017 A1
20170296770 Gunaratnam et al. Oct 2017 A1
20170304574 McAuley et al. Oct 2017 A1
20170368288 Stephens et al. Dec 2017 A1
20180250483 Olsen et al. Sep 2018 A1
20180256844 Galgali et al. Sep 2018 A1
20190001095 Rose et al. Jan 2019 A1
20190030273 McAuley et al. Jan 2019 A1
20200016357 McAuley et al. Jan 2020 A1
20200046928 Allan Mar 2020 A1
20200108219 McAuley et al. Apr 2020 A1
20200164169 McAuley et al. May 2020 A1
20200171260 McLaren Jun 2020 A1
20200197644 McAuley et al. Jun 2020 A1
20200268997 McAuley et al. Aug 2020 A1
20200268998 McAuley et al. Aug 2020 A1
20210228829 McAuley et al. Jul 2021 A1
20210386951 McAuley et al. Dec 2021 A1
20210402121 McAuley et al. Dec 2021 A1
Foreign Referenced Citations (189)
Number Date Country
2003246441 Dec 2003 AU
20100334468 Aug 2012 AU
2009321054 Jul 2015 AU
1311662 Dec 1992 CA
2648690 Nov 2007 CA
000966064-0001 Sep 2008 CD
000966064-0002 Sep 2008 CD
000966064-0003 Sep 2008 CD
000966064-0004 Sep 2008 CD
000966064-0017 Sep 2008 CD
2172538 Jul 1994 CN
1780265 Dec 2005 CN
1751149 Mar 2006 CN
1784250 Jun 2006 CN
1901961 Jan 2007 CN
1905917 Jan 2007 CN
101115521 Jan 2008 CN
101214402 Jul 2008 CN
100502972 Jun 2009 CN
101516300 Aug 2009 CN
101541380 Sep 2009 CN
101991897 Mar 2011 CN
895692 Nov 1953 DE
29723101 Jul 1998 DE
19603949 Nov 1998 DE
10312881 May 2004 DE
102005041717 Apr 2006 DE
102006011151 Sep 2007 DE
0 350 322 Jan 1990 EP
0 427 474 May 1991 EP
0 462 701 Dec 1991 EP
0 747 078 Dec 1996 EP
1 099 452 May 2001 EP
0 830 180 Mar 2002 EP
1 258 266 Nov 2002 EP
1 488 820 Dec 2004 EP
1 582 231 Oct 2005 EP
2 042 209 Apr 2009 EP
2 130 563 Dec 2009 EP
2 145 645 Jan 2010 EP
1 753 495 Sep 2010 EP
1 481 702 Sep 2012 EP
2 749 176 Jul 2014 EP
1 646 910 Aug 2015 EP
2 022 528 Mar 2016 EP
2 451 518 Oct 2017 EP
2658725 Aug 1991 FR
2749176 Dec 1997 FR
190224431 Dec 1902 GB
880824 Oct 1961 GB
979357 Jan 1965 GB
1467828 Mar 1977 GB
2133275 Jul 1984 GB
2173274 Oct 1986 GB
2186801 Aug 1987 GB
2385533 Aug 2003 GB
62-024721 Feb 1987 JP
H09-010311 Jan 1997 JP
2000-325481 Nov 2000 JP
2004-016488 Jan 2004 JP
2005-529687 Oct 2005 JP
2005-537906 Dec 2005 JP
2007-516750 Jun 2007 JP
531332 Feb 2004 NZ
534606 Aug 2004 NZ
528029 Mar 2005 NZ
548575 Jul 2006 NZ
551103 Nov 2006 NZ
WO 82003548 Oct 1982 WO
WO 9732494 Sep 1997 WO
WO 9804310 Feb 1998 WO
WO 98004310 Feb 1998 WO
WO 9804311 Feb 1998 WO
WO 98018514 May 1998 WO
WO 98024499 Jun 1998 WO
WO 98048878 Nov 1998 WO
WO 9857691 Dec 1998 WO
WO 9904842 Feb 1999 WO
WO 9943375 Sep 1999 WO
WO 99058181 Nov 1999 WO
WO 99058198 Nov 1999 WO
WO 00050122 Aug 2000 WO
WO 00057942 Oct 2000 WO
WO 00069497 Nov 2000 WO
WO 0074509 Dec 2000 WO
WO 00074758 Dec 2000 WO
WO 00078384 Dec 2000 WO
WO 0100266 Jan 2001 WO
WO 0132250 May 2001 WO
WO 01041854 Jun 2001 WO
WO 01058293 Aug 2001 WO
WO 01062326 Aug 2001 WO
WO 0194721 Dec 2001 WO
WO 0197892 Dec 2001 WO
WO 01097892 Dec 2001 WO
WO 01097893 Dec 2001 WO
WO 02005883 Jan 2002 WO
WO 02011804 Feb 2002 WO
WO 02047749 Jun 2002 WO
WO 02074372 Sep 2002 WO
WO 03035156 May 2003 WO
WO 03076020 Sep 2003 WO
WO 03082406 Oct 2003 WO
WO 03092755 Nov 2003 WO
WO 04007010 Jan 2004 WO
WO 04096332 Jan 2004 WO
WO 04012803 Feb 2004 WO
WO 04022146 Mar 2004 WO
WO 04022147 Mar 2004 WO
WO 04030736 Apr 2004 WO
WO 04041341 May 2004 WO
WO 04041342 May 2004 WO
WO 04052438 Jun 2004 WO
WO 04071565 Aug 2004 WO
WO 04073777 Sep 2004 WO
WO 04073778 Sep 2004 WO
WO 05010608 Feb 2005 WO
WO 05016403 Feb 2005 WO
WO 05018523 Mar 2005 WO
WO 05021075 Mar 2005 WO
WO 05051468 Jun 2005 WO
WO 05063326 Jul 2005 WO
WO 05063328 Jul 2005 WO
WO 05076874 Aug 2005 WO
WO 05079726 Sep 2005 WO
WO 05086943 Sep 2005 WO
WO 05086946 Sep 2005 WO
WO 05097247 Oct 2005 WO
WO 05123166 Dec 2005 WO
WO 06000046 Jan 2006 WO
WO 06050559 May 2006 WO
WO 06069415 Jul 2006 WO
WO 06074513 Jul 2006 WO
WO 06074514 Jul 2006 WO
WO 06074515 Jul 2006 WO
WO 06096924 Sep 2006 WO
WO 06130903 Dec 2006 WO
WO 06138346 Dec 2006 WO
WO 06138416 Dec 2006 WO
WO 07006089 Jan 2007 WO
WO 07009182 Jan 2007 WO
WO 07021777 Feb 2007 WO
WO 07022562 Mar 2007 WO
WO 07041751 Apr 2007 WO
WO 07041786 Apr 2007 WO
WO 07045008 Apr 2007 WO
WO 07048174 May 2007 WO
WO 07053878 May 2007 WO
WO 07114492 Oct 2007 WO
WO 07147088 Dec 2007 WO
WO 08007985 Jan 2008 WO
WO 08011682 Jan 2008 WO
WO 08014543 Feb 2008 WO
WO 08030831 Mar 2008 WO
WO 08036625 Mar 2008 WO
WO 08060295 May 2008 WO
WO 08068966 Jun 2008 WO
WO 08070929 Jun 2008 WO
WO 08106716 Sep 2008 WO
WO 08148086 Dec 2008 WO
WO 09026627 Mar 2009 WO
WO 09022248 Apr 2009 WO
WO 09052560 Apr 2009 WO
WO 09059353 May 2009 WO
WO 09092057 Jul 2009 WO
WO 09139647 Nov 2009 WO
WO 10066004 Jun 2010 WO
WO 10073142 Jul 2010 WO
WO 10131189 Nov 2010 WO
WO 10135785 Dec 2010 WO
WO 10148453 Dec 2010 WO
WO 11014931 Feb 2011 WO
WO 11059346 May 2011 WO
WO 11060479 May 2011 WO
WO 11077254 Jun 2011 WO
WO 12040791 Apr 2012 WO
WO 12045127 Apr 2012 WO
WO 12052902 Apr 2012 WO
WO 12143822 Oct 2012 WO
WO 14020469 Feb 2014 WO
WO 14109749 Jul 2014 WO
WO 14175752 Oct 2014 WO
WO 14175753 Oct 2014 WO
WO 15033287 Mar 2015 WO
WO 16000040 Jan 2016 WO
WO 17049356 Mar 2017 WO
WO 17049357 Mar 2017 WO
WO 18007966 Jan 2018 WO
WO 18064712 Apr 2018 WO
Non-Patent Literature Citations (215)
Entry
Canadian Examination Report in patent application No. 3010066, dated Dec. 19, 2019, 4 pages.
Chinese Fourth Office Action in patent application No. 201610116121.1, dated Sep. 30, 2019, 12 pages.
Chinese Third Examination Report in patent application No. 201610114706.X, dated Jan. 16, 2020, with translation.
Chinese First Office Action in patent application No. 201710824612.6, dated Sep. 30, 2019 , 25 pp.
European examination report dated Sep. 5, 2019 in patent application No. 18163847.9, 5 pp.
Japanese office action dated Sep. 1, 2019 in patent application No. 2018-188040.
Japanese Pretrial Examination Report dated Jan. 7, 2020 in patent application No. 2017-238259.
Scheduling Order dated Jul. 16, 2019 in IPR2019-00180, 12 pp.
Decision to Institute dated Jul. 16, 2019 in IPR2019-00180, 34 pp.
Decision Denying Institute of Inter Partes Review dated Jul. 16, 2019 in IRP2019-00179, 32 pp.
Australian examination report in patent application No. 2018236891, dated Jun. 9, 2020, 3 pages.
Australian Examination Report No. 2 for patent application No. 2018217307, dated Mar. 3, 2020, 4 pp.
Australian Examination Report No. 1 in patent application No. 2019280016, dated Jul. 22, 2020.
Brazilian office action dated Aug. 28, 2020 in patent application No. PI1012207-9.
Canadian Examination Report in patent application No. 3017161, dated Apr. 22, 2020, 4 pp.
Canadian Examination Report for patent application No. 2880749, dated Feb. 28, 2020, 4 pp.
Chinese Fourth Examination Report in patent application No. 201610114706.X, dated Aug. 28, 2020, with translation.
Chinese Second Office Action in patent application No. 201710824612.6, dated May 25, 2020.
European Examination Report, European Application 13828380.9, dated Mar. 3, 2020, 8 pp.
European examination report dated Jun. 16, 2020 in patent application No. 18163847.9, 5 pp.
European Examination Report dated Mar. 16, 2020 in patent application No. 18195537.8.
European Search Report in patent application No. 191976761.1, dated Mar. 3, 2020, 10 pages.
European Extended Search Report dated Jul. 7, 2020 in patent application No. 19217524.8, 13 pp.
German examination report dated Aug. 31, 2020 in patent application No. 11 2010 011 994.0, 18 pp.
U.S. Appl. No. 60/493,515, filed Aug. 8, 2002, Sleeper et al.
U.S. Appl. No. 60/496,059, filed Aug. 18, 2003, Ho et al.
U.S. Appl. No. 60/529,696, filed Dec. 16, 2003, Lithgow et al.
U.S. Appl. No. 61/064,406, filed Mar. 4, 2008, Wehbeh.
U.S. Appl. No. 61/071,893, filed May 22, 2008, Wehbeh et al.
U.S. Appl. No. 61/136,617, filed Sep. 19, 2008, Wehbeh et al.
Resmed Mirage Swift™ II Nasal Pillows System product page (http://www.resmed.com/en-us/products/masks/mirage_swift_II_nasal_pillows._system/Mirage-Swift-II-Nasal-Pillows-System.html?menu=products); archived Jul. 21, 2008, 2 pp.
Resmed Mirage Swift™ II user brochure (http://www.resmed.com/en us/products/masks/mirage-swift_ii_nasal_pillows_system/documents/mirage-swift-ii-np-brochure-patient-english-usa.pdf) copyright 2007, 4 pp.
ResMed Mirage Swift II Fitting guide (http://www;resmed.com/en-us/products/masks/miraqge_swift_IInasal_pillows_system/documents/mirage-swift_ii_np-fitting_English.pdf) copyright 2006, 2 pp.
ResMed Mirage Swift II comparison to older Swift patient interface (http://www.resmed.com/en-us/products/masks/mirage_swift_II_nasal_pillows_system/documents/mirage-swift-ii-np-comparison-guide.pdf, 2007, 6 pp.
ResMed Mirage Swift II user guide (http://www.resmed.com/en-us/products/service_and_support/documents/60893ri_mirage_swiftII_nasal_userglide_US_multi.pdf) copyright 2006, 1 p.
ResMed Mirage Swift II component card (http://www.resmed.com/en-us/products/masks/mirage_swift_II_nasal_pillows_system/documents/mirage-swift-ii-np-cc-usa.pdf); copyright 2006, 2 pp.
Resmed Swift™ LT Nasal Pillows System, product page, (http://www.resmed.com/en-us/products/masks/mirage_swift_II_nasal_pillows_system/Mirage-Swift-II-Nasal_Piilows-System.html?menu=products), Jul. 3, 2008, 2 pp.
Resmed Swift LT user brochure, (http://www.resmed.com/en-us/products/masks/mirage_swift_II_nasal_pillows_system/documents/mirage-swift-ii-np-brochure-patient-english-usa.pdf), copyright 2008, 4 pp.
Resmed Swift™ LT component card (http://www.resmed.com/en-us/assets/documents/product/swift_lt/components_card/1012463_swift-lt_components-card_usa_eng.pdf) copyright 2008, 46 pp.
Resmed Swift™ LT filling guide, (http://www.resmed.com/en-us/assets/documents/product/swift-II/clinical_fact_sheet/1012406 swift-ii_fact-sheet_usa_eng.pdf), 2008, 2 pp.
Resmed Swift™ LT fact sheet (http://www.resmed.com/en-us/assets/documents/product/swift-lt/clinical_fact_sheet/1012406 swiftlt_fact-sheet_usa_eng.pdf, copyright 2008, 4 pp.
Resmed Swift™ LT image gallery (http://www.resmed.com/en-us/products/masks/swift_lt_nasal_pillows_system/imagegallery.html?menu=products, Apr. 25, 2008, 2 pp.
Resmed Swift™ LT interactive fitting guide—screenshot from troubleshooting part (http://www.resmed.com/enus/assets/multimedia/product/swift-lt/flash/swift-lt-fitting-eng.swf), Jul. 3, 2008, 2 pp.
Puritan Bennett Breeze® SleepGear® CPAP Interface, product page (http:/puritanbennett.com/prod/product.aspx?id=233); archived Oct. 19, 2007, 2 pp.
Puritan Bennett Breeze® SleepGear® User's Guide (http://puritanbennett.com/_catalog/pdf/dfu/107598a00[I].pdf); copyright 2007, 18 pp.
Puritan Bennett Breeze® SleepGear® sales sheet (http://www.puritanbennett.com/_Catalog/PDF/Product/BreezeSleepGear.pdf) copyright 2016, 7 pp.
Puritan Bennett mask coding matrix (http://www.puritanbennett.com/_Catalog/PDF/Product/BreezeSlpGear(ST03700).pdf) copyright 2006, 3 pp.
Puritan Bennett Breeze fitting guide (http://www.puritanbennett.com/_Catalog/PDF/Product/BreezeFittingPoster.pdf, Oct. 19, 2007, 1 p.
Respironics Optilife Pillows mask product page (http://optilife.respironics.com:80/); archived Nov. 21, 2007, 2 pp.
Respironics Optilife Pillows mask part numbers page (http://optilife.respironics.com:80/Parts.aspx); archived Nov. 23, 2007, 4 pp.
Respironics Optilife Pillows mask FAQ (http;//optilife.respironics.com:80/fags.aspx); archived Nov. 23, 2007, 6 pp.
Respironics Optilife Pillows mask feature page (http://opti1ife.respironics.com:80/features.aspx); archived Nov. 23, 2007, 4 pp.
Respironics Optilife Pillows mask fitting guide screen shot (http://optilife.respironics.com:80/fittingGuide.aspx); archived Aug. 7, 2008, 1 p.
Respironics Optilife Pillows mask adjustment video screenshots, https://www.youtube.com/watch?v=shjcNmvvcBA); uploaded Aug. 3, 2008, 2 pp.
Puritan Bennett Breeze description; copyright 2000 by Mallinckrodt Inc., 4 pp.
Fisher & Paykel Opus product page, archived Sep. 3, 2009, 2 pp.
Fisher & Paykel Opus patient interface product photographs, Jul. 2007, 6 pp.
Photographs of Opus 360 nasal pillows mask patient instructions RevB, Jul. 2007, 4 pp.
Respironics Optilife brochure detailing updates; copyright 2008; dated Mar. 26, 2008, 3 pp.
Fisher & Paykel Opus product page, archived Sep. 7, 2009, 2 pp.
Fisher & Paykel Opus “Off-the-lips” pillows explanation page, archived Aug. 23, 2009, 2 pp.
Fisher & Paykel Opus “Off-the-lips” patient interface brochure, archived Oct. 14, 2009, 6 pp.
Fisher & Paykel Opus user-guide, archived Nov. 17, 2009, 2 pp.
Fisher & Paykel HC200 Series Nasal CPAP Blower & Heated Humidifier User Manual, 17 pp., May 1998.
Fisher & Paykel Healthcare, FlexiFit® 431 Full Face Mask instructions, 2010, 4 pp.
Fisher & Paykel Healthcare, FlexiFit™ 431 Full Face Mask, specification sheet, 2004, 2 pp.
Fisher & Paykel Healthcare, Interface Solutions Product Profile, 2006, 12 pp.
Fisher & Paykel MR810 Manual, Rev. C, 2004, 43 pp.
HomeDepot.com—Ring Nut Sales Page (Retrieved Oct. 16, 2015 from http://www.homedepot.com/p/Everbilt-1-2-in-Galvanized-HexNut-804076/20464-7893), 4 pp.
Malloy, 1994, Plastic Part Design for Injection Molding, Hanswer Gardner Publications, Inc, Cincinnati, OH, 14 pp.
Merriam-Webster's Collegiate Dictionary, Eleventh Edition, 2004, pp. 703, 905, 1074, 1184.
Philips Respironics ‘System One Heated Humidifier—User Manual’, 2011, pp. 1-16, [retrieved on Nov. 25, 2013] from the internet: URL: http://www.cpapxchange.com/cpap-machines-biap-machines/system-one-60-seri-es-cpap-humidifier-manual.pdf front cover, pp. 3-4 and 6.
ResMed Exhibit, FlexiFit™ 431, product brochure, web pages (Wayback Machine), 2006, 23 pp.
ResMed Origins Brochure (Retrieved Apr. 17, 2016 from http://www.resmed.com/us/dam/documents/articles/resmedorigins.pdf), 64 pp.
ResMed Ultra Mirage™ Full Face Mask, product brochure, 2004, 2 pp.
ResMed Ultra Mirage™ Full Face Mask, product brochure, web pages (Wayback Machine), 2006, 9 pp.
ResMed, Jun. 29, 1997, Mask Frames (Source: Wayback Machine Internet Archive); http://web.archive.org/web/19970629053430/http://www.resmed.com-/maskframes/mask.htm, 2 pp/.
ResMed, Mirage Swift™ Nasal Pillows System from ResMed, product brochure, 2004, 6 pp.
ResMed, Mirage Swift™ Nasal Pillows System: User's Guide, product brochure, 2004,11 pp.
ResMed, Mirage Vista™ Nasal Mask: Components Card, product brochure, 2005, 1 p.
The American Heritage Dictionary of the English Language, Fourth Edition, 2006, pp. 1501, 1502, 1650.
WeddingBands.com—Men's Wedding Ring Shopping Page (Retrieved Oct. 16, 2015 from http://www.weddingbands.com/ProductPop.sub.--wedding.sub.--band-s.sub.--metal/48214W.html), 3 pp.
Australian Examination Report No. 1, in patent application No. AU 2013300237, dated Jun. 8, 2017, in 4 pages.
Australian Examination Report in patent application No. 2016238904 dated May 4, 2018, 5 pages.
Australian Examination Report in patent application No. 2012265597 dated Dec. 19, 2013, 5 pages.
Australian Examination Report in patent application No. 2015201920, dated Jul. 20, 2015, 3 pages.
Australian Examination Report in patent application No. 2007273324, dated May 22, 2012, 3 pages.
Australian Examination Report in patent application No. 2010241390, dated Jan. 9, 2015, 4 pages.
Australian Examination Report in patent application No. 2010241390, dated Sep. 28, 2016, 4 pages.
Australian Examination Report in patent application No. 2010246985, dated Mar. 4, 2014, 5 pages.
Australian Examination Report in patent application No. 2015202814, dated Aug. 14, 2015, 8 pages.
Australian Examination Report in patent application No. 2016202799, dated May 31, 2016, 2 pages.
Australian examination report in patent application No. 2016202801, dated Jun. 20, 2016, 2 pages.
Australian Examination Report in patent application No. 2016204384, dated Aug. 5, 2016, 2 pages.
Australian examination report in patent application No. 2017200991, dated Oct. 13, 2017, 3 pages.
Australian examination report in patent application No. 2017201021, dated Apr. 7, 2017, 6 pages.
Canadian Examination Report in patent application No. 2655839, dated Oct. 4, 2013, 2 pages.
Canadian Examination Report in patent application No. 2780310, dated Jul. 26, 2016, 4 pages.
Canadian Examination Report in patent application No. 2780310, dated Jan. 25, 2018 4 pages.
Canadian Examination Report in patent application No. 2780310, dated Oct. 9, 2018, 3 pp.
Canadian Examination Report in patent application No. 2890556, dated Jan. 27, 2016, 3 pages.
Canadian Examination Report in patent application No. 2890556, dated Nov. 28, 2016, 4 pages.
Canadian Examination Report in patent application No. 2918167, dated Oct. 3, 2016, 4 pages.
Chinese Examination Report in patent application No. 2007800266164, dated Feb. 17, 2011, 5 pages.
Chinese Examination Report in patent application No. 201080028029.0, dated Mar. 27, 2014, 16 pages.
Chinese Second Office Action in patent application No. 201080028029.0, dated Jan. 19, 2015, 16 pages.
Chinese Examination Report in patent application No. 201080028029.0, dated Sep. 14, 2015, 3 pages.
Chinese Examination Report in patent application No. 201080061122.1, dated Jul. 17, 2915, 10 pages.
Chinese Examination Report in patent application No. 201080061122.1, dated Sep. 3, 2015, 10 pages.
Chinese First Office Action in patent application No. 201210080441.8, dated Mar. 24, 2014, 4 pages.
Chinese Second Office Action for Chinese Patent Application No. 201210980441.8 dated Dec. 1, 2014 in 11 pages (with English translation).
Chinese Office Action in patent application No. 201610116121.1, dated Sep. 28, 2017, 5 pages.
Chinese Third Office Action in patent application No. 201080061122.1, dated Apr. 1, 2016, 5 pages.
Chinese Examination Report in patent application No. 201610114706.X, dated Jul. 30, 2018, 9 pp., with translation.
European Extended Search Report; dated Apr. 2, 2014; Application No. 09819444.2; 8 pages.
European Examination Report in patent application No. 07808683.2, dated Jul. 8, 2015, 8 pages.
European Examination Report in patent application No. 07808683.2, dated May 9, 2018, 3 pages.
European Search Report and Written Opinion dated May 12, 2016 in patent application No. 09746823.5; 11 pages.
European Summons to Attend Oral Proceedings and Written Opinion dated Dec. 13, 2017 in patent application No. 09746823.5; 7 pages.
European Examination Report in patent application No. 09746823.5, dated Apr. 3, 2017, 2 pages.
European Extended Search Report in patent application No. 10774623.2, dated Sep. 8, 2015, 7 pages.
European Extended Search Report in patent application No. 10839251.4, dated Sep. 4, 2015, 7 pages.
European Examination Report, European Application 13828380.9, dated Apr. 7, 2017, 7 pp.
European Examination Report, European Application 13828380.9, dated Jul. 27, 2018, 8 pp.
European extended search report dated Jul. 23, 2018 in patent application No. 18163847.9, 7 pp.
European extended search report dated Sep. 21, 2018 in patent application No. 18178220.2, 7 pp.
European extended search report dated Oct. 31, 2018 in patent application No. 18171619.2, 9 pp.
European Extended Search Report in patent application No. 17179765.7, dated Dec. 11, 2017.
European Search Report in patent application No. 11830981.4, dated Aug. 24, 2015, 6 pages.
Great Britain Combined Search and Examination Report in patent application No. GB1406401.8, dated May 7, 2014, 4 pages.
Great Britain Combined Search and Examination Report in patent application No. GB1406402.6, dated May 7, 2014, 6 pages.
Great Britain Examination Report in patent application No. GB1119385.1, dated May 9, 2013, 4 pages.
Great Britain Search and Examination Report, in patent application No. GB1210075.6, Mar. 14, 2013, 2 pages.
Great Britain Combined Search and Examination Report in patent application No. GB1719334.3, dated Nov. 30, 2017, in 9 pages.
Great Britain examination report dated May 30, 2018 in patent application No. GB1719334.3, 4 pp.
Great Britain examination report dated Jul. 20, 2018 In patent application No. GB1719334.3, 3 pp.
Great Britain combined search and examination report dated May 11, 2018 in patent application No. GB1805606.9, 7 pp.
Great Britain examination report dated Jul. 5, 2018 in patent application No. GB1805606.9, 3 pp.
Great Britain examination report dated May 11, 2018 in patent application No. GB1803255.7, 7 pp.
Great Britain examination report dated May 11, 2018 in patent application No. GB1805605.1, 7 pp.
Great Britain examination report in patent application No. GB1501499.6, dated Jun. 1, 2017, in 8 pages.
Great Britain Combined Search and Examination Report under Section 18(3), Application No. GB1501499.6, dated Oct. 12, 2017, in 4 pages.
International Search Report for application No. PCT/NZ2005/000062 dated May 27, 2005.
International Search Report for International application No. PCT/NZ2007/000185, dated Oct. 31, 2007, in 3 pages.
International Search Report, PCT/NZ2009/000072, dated Jul. 28, 2009, 4 pages.
International Search Report, International application No. PCT/NZ2009/000219, dated Feb. 2, 2010, 3 pages.
International Preliminary Report on Patentability (IPRP), International application No. PCT/NZ2009/000219, dated Apr. 12, 2011, 9 pages.
International Search Report, PCT/NZ2010/000229, dated Mar. 18, 2011, 8 pages.
International Preliminary Report on Patentability and Written Opinion of the ISA, International application No. PCT/NZ2010/000229, dated May 22, 2012, 14 pages.
Written Opinion of the International Searching Authority, PCT/NZ2010/000229, dated Mar. 18, 2011, 13 pages.
International Search Report, PCT/NZ2011/000211, dated Feb. 17. 2012, 4 pages.
Written Opinion, PCT/NZ2011/000211, dated Feb. 17, 2012, 7 pages.
International Search Report, application No. PCT/NZ2013/000138, dated Nov. 1, 2013, 7 pages.
Written Opinion of the International Searching Authority, PCT/NZ2013/000139, dated Nov. 1, 2013.
International Search Report for international application No. PCT/NZ2014/000021, filed Feb. 21, 2014.
Indian Office Action in Patent Application No. 5250/KOLNP/2008, dated May 23, 2017, 8 pages.
Japanese Examination Report in patent application No. 2012-510418, dated Feb. 10, 2014, 4 pages.
Japanese Examination Report in patent application No. 2012-538784, dated Aug. 25, 2014, 3 pages.
Japanese Examination Report in patent application No. 2012-538784, dated Aug. 5, 2015, 8 pages.
Japanese Examination Report in patent application No. 2012-538784, dated Jul. 25, 2016, 2 pages.
Japanese Examination Report in patent application No. 2015-098324, dated Jul. 22, 2015, 8 pages.
Japanese Examination Report in patent application No. 2017-040092, dated Feb. 5, 2018.
Japanese Official Action dated Sep. 3, 2018 in patent application No. 2017-238259.
Japanese examination report in patent application No. 2015-526496, dated Apr. 17, 2017, in 13 pages.
Japanese Examination Report in patent application No. 2015-526496, dated Feb. 28, 2018, 2 pp.
U.S. Appl. No. 61/064,406, 34 pages.
U.S. Appl. No. 61/071,893, 43 pages.
U.S. Appl. No. 61/136,617, 82 pages.
Petition for Inter Partes Review of U.S. Pat. No. 8,479,741 Pursuant to 35 U.S.C. §§ 311-19, 37 C.F.R. § 42, IPR2016-01714, dated Sep. 7, 2016.
Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,479,741, IPR2016-01714, filed Dec. 14, 2016.
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,479,741 Pursuant to 37 C.F.R. § 42.108, IPR2016-01714, entered Mar. 10, 2017.
Declaration of Dr. John Izuchukwu, Ph.D., P.E., U.S. Pat. No. 8,443,807, IPR Nos. 2016-1726 & 2016-1734, dated Sep. 7, 2016.
Declaration of Dr. John Izuchukwu, Ph.D., P.E., U.S. Pat. No. 8,479,741, IPR Nos. 2016-1714 & 2016-1718, dated Sep. 7, 2016.
Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,479,741, IPR2016-01718, filed Dec. 16, 2016.
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,479,741 Pursuant to 37 C.F.R. § 42.108, IPR2016-01718, entered Mar. 13, 2017.
Petition for Inter Partes Review of U.S. Pat. No. 8,479,741 Pursuant to 35 U.S.C. §§ 311-19, 37 C.F.R. § 42, IPR2016-01718, dated Sep. 7, 2016.
Petition for Inter Partes Review of U.S. Pat. No. 8,443,807 Pursuant to 35 U.S.C. §§ 311-19, 37 C.F.R. § 42, IPR2016-01726, dated Sep. 7, 2016.
Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,443,807, IPR2016-01726, filed Dec. 13, 2016.
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,443,807 Pursuant to 37 C.F.R. § 42.108, IPR2016-01726, entered Mar. 6, 2017.
Petition for Inter Partes Review of U.S. Pat. No. 8,443,807 Pursuant to 35 U.S.C. §§ 311-19, 37 C.F.R. § 42, IPR2016-01734, dated Sep. 7, 2016.
Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,443,807, IPR2016-01734, filed Dec. 22, 2016.
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,443,807 Pursuant to 37 C.F.R. § 42.108, IPR2016-01734, entered Mar. 13, 2017.
File History of U.S. Pat. No. 8,479,741 to McAuley et al, published Oct. 1, 2009.
File History of U.S. Pat. No. 8,443,807 to McAuley et al, published Jan, 7, 2010.
Patent Owner's Complaint for Fisher & Paykel Healthcare Ltd. v. ResMed Corp., Case No. 2:16-cv-06099-R-AJW (C.D. Cal.), dated Aug. 15, 2016.
Patent Owner's Notice of Voluntary Dismissal Without Prejudice for Fisher & Paykel Healthcare Ltd. v. ResMed Corp., Case No. 2:16-cv-06099-R-AJW (C.D. Cal.), dated Aug. 16, 2016.
Patent Owner's Complaint for Fisher & Paykel Healthcare Ltd. v. ResMed Corp., Case No. 3:16-cV-02068-GPC-WVG (S.D. Cal.), dated Aug. 16, 2016.
Petitioners' Complaint for ResMed Inc., et al. v. Fisher & Paykel Healthcare Corp. Ltd., et al., Case No. 3:16-cv-02072-JAH-MDD (S.D. Cal.), dated Aug. 16, 2016.
Petitioners' Notice of Voluntary Dismissal Without Prejudice for ResMed Inc., et al. v. Fisher & Paykel Healthcare Corp. Ltd., et al., Case No. 3:16-cv-02072-JAH-MDD (S.D. Cal.), dated Aug. 18, 2016.
Statutory Declaration made by Alistair Edwin McAuley, Apr. 9, 2015, in the matter of an Opposition by Fisher & Paykel Healthcare Limited of Australian patent application 2009221630 in the name of ResMed Limited.
Statutory Declaration made by Alistair Edwin McAuley, Apr. 14, 2015, in the matter of an Opposition by Fisher & Paykel Healthcare Limited of Australian patent application 2009221630 in the name of ResMed Limited.
Statutory Declaration made by Alistair Edwin McAuley, Apr. 17, 2015, in the matter of an Opposition by Fisher & Paykel Healthcare Limited of Australian patent application 2009221630 in the name of ResMed Limited.
Statutory Declaration made by Alistair Edwin McAuley, Sep. 16, 2015, in the matter of an Opposition by Fisher & Paykel Healthcare Limited of Australian patent application 2009221630 in the name of ResMed Limited.
First Affidavit of Alistair Edwin McAuley, Dec. 5, 2016, in the matter of Fisher and Paykel Healthcare Limited v. ResMed Limited filed in the Federal Court of Australia.
Second Affidavit of Alistair Edwin McAuley, Dec. 21, 2016, in the matter of Fisher and Paykel Healthcare Limited v. ResMed Limited filed in the Federal Court of Australia.
Third Affidavit of Alistair Edwin McAuley, Jan. 31, 2017, in the matter of Fisher and Paykel Healthcare Limited v. ResMed Limited filed in the Federal Court of Australia, 284 pp.
Declaration of Anthony Michael Ging in IPR 2019-000172, IPR 2019-000173, IPR 2019-000177, IPR 2019-000178, dated Nov. 8, 2018, 329 pp.
McGraw-Hill Dictionary of Scientific and Technical Terms, Sixth Edition, 2003, Tube, p. 2200.
Claim Chart for AirFit P10, U.S. Pat. No. 9,333,315, dated Nov. 7, 2018, 3 pp.
Australian examination report in patent application No. 2018202409, dated Jan. 21, 2019, 4 pages.
Australian examination report in patent application No. 2018201975, dated Mar. 30, 2019, 4 pages.
Australian examination report in patent application No. 2018217307, dated Mar. 4, 2019, 4 pages.
Australian examination report in patent application No. 2018236891, dated Jun. 25, 2019, 3 pages.
Brazilian office action dated Jul. 11, 2019 in patent application No. BR11201211420-4.
Canadian Examination Report in patent application No. 2998247, dated Jan. 8, 2019, 4 pages.
Canadian Examination Report in patent application No. 3010066, dated May 3, 2019, 4 pages.
Canadian Examination Report in patent application No. 2880749, dated May 16, 2019, 5 pages.
Canadian Examination Report in patent application No. 3017161, dated Aug. 21, 2019, 3 pp.
Chinese Third Office Action in patent application No. 201610116121.1, dated Apr. 28, 2019, 16 pages.
Chinese Second Examination Report in patent application No. 201610114706.X, dated Apr. 24, 2019 8 pp., with translation.
Chinese Examination Report dated Feb. 22, 2019 in patent application No. 201611251618.0.
European Extended Search Report dated Feb. 14, 2019 in patent application No. 18195537.8.
Indian Examination Report in patent application No. 1431/KOLNP/2012.
Indian Examination Report in patent application No. 8767/CHENP/2011.
Japanese Decision for Final Rejection dated Jul. 1, 2019 in patent application No. 2017-238259, 2 pp.
Related Publications (1)
Number Date Country
20190232010 A1 Aug 2019 US
Continuations (3)
Number Date Country
Parent 15947021 Apr 2018 US
Child 16378212 US
Parent 14333134 Jul 2014 US
Child 15947021 US
Parent 10598026 US
Child 14333134 US